The Paradigm Shift in Cancer Care: Embracing Minimally Invasive Diagnostics The field of oncology diagnostics is undergoing a monumental shift, moving away from invasive and logistically complex tissue biopsies toward sophisticated, minimally invasive blood tests. This technology, known as liquid biopsy, analyzes biomarkers—such as circulating tumor cells (CTCs) or circulating tumor DNA (ctDNA)—shed by tumors into bodily fluids. Its appeal lies in its...
จองคิวบริการ
NR tours
Youplay
NR shop
NR jobs
facebook th
